Home News Company News
A Comprehensive Showcase: Fapon Biotech Attends MEDICA 2022 with Latest IVD Innovations

(Nov.17, 2022, Düsseldorf, Germany) From November 14 to 17, 2022, Fapon Biotech Inc. (Fapon Biotech or the Company) attended the MEDICA trade fair in Düsseldorf, Germany. At the show, Fapon Biotech presented its upgraded product portfolio, including core IVD raw materials, reagent services and open instrument platforms.

MEDICA attracts several thousand exhibitors from more than 50 countries each year, and leading professionals from the fields of health, business, research, and policy participate in this top-class event, meeting with national and international experts and decision-makers from relevant sectors. With over two decades of R&D experience and extensive resources from across the globe, Fapon Biotech is now a leading upstream company in the China life sciences industry and in the global IVD industry. The Company met with worldwide IVD partners at MEDICA, showcasing its advancements and latest IVD innovations.

Excellent IVD Raw Materials and Reagent Services Featured

Fapon Biotech provides over 1300 antibodies, antigens, enzymes, blockers, and more on different technology platforms of chemiluminescence, ELISA, rapid test, immunoturbidimetry, PCR and NGS. Highlighted raw materials and reagent services were introduced by the Fapon team at the exhibition booth, such as cardiac marker, tumor marker, respiratory disease, inflammatory marker, tropical disease, infectious disease, drug of abuse, polymerase & mix, reverse transcriptase & mix, LAMP polymerase, PCR miscellaneous, and many more.

As a leading supplier of excellent IVD raw materials and customized solutions, Fapon Biotech has continuously developed and optimized its product portfolio to accelerate downstream diagnostic companies’ disease testing. It is worth mentioning that Fapon Biotech has developed testing solutions and provided COVID-19 testing raw materials for more than 10 billion tests globally since the outbreak of the COVID-19 pandemic. In addition, Fapon Biotech has provided malaria testing raw materials for over 200 million tests every year, bolstering local governments and enterprises’ diseases testing capacities and costs reductions, and contributing to the global eradication of malaria.

Open Instrument Platform on Show

Fapon Biotech also presented four instruments at its booth, namely the Shine i1000 chemiluminescence immunoassay analyzer, Shine i2000 chemiluminescence immunoassay analyzer, P810 real-time PCR analyzer and the iCatch2000 rapid molecular point-of-care analyzer. Equipped with Fapon Biotech’s excellent core raw materials and reagent services, these instruments can provide a one-stop solution for chemiluminescence immunoassay and Ultra-fast PCR, respectively.

Expansive Chemiluminescence Ecosystem Empowering Partners

In accordance with the mission of enabling timely, accurate and affordable diagnosis for all, Fapon Biotech aims to empower partners to transform them from dealers to manufacturers. The Company aims to achieve this through the launch of its expansive ecosystem concept for Chemiluminescence immunoassay. Fapon Biotech introduced its self-developed series of high-performance chemiluminescence immunoassay analyzers that are open and fully customizable: the smallest fully automatic chemiluminescence immunoassay analyzer, the Shine i1000, which is compatible with AE and AP chemiluminescence protocols; compact yet robust and large capacity analyzer, the Shine i2000, which is compatible with AE, AP, HRP, ABEI protocols.

With over two decades of experience in the IVD industry, Fapon Biotech has established a comprehensive technology platform and developed a wide range of product lines. It can now provide compact, accurate and affordable chemiluminescence analyzers with Fapon ecosystem reagent panels. The source of the reagents include Fapon’s self-developed reagents and partners’ development reagents, and all reagents have passed the Company’s own strict reagent verification system, which ensures the quality of all reagents. Aside from this, technical services such as factory construction design, product registration support, construction of quality assurance system, professional and quick customer services are also provided.

Fapon Biotech will continue to harness its global innovation network and leverage other notable trade fairs that connect the entire world to continue to enable timely, accurate and affordable diagnosis for all by providing more exceptional products and solutions, and accelerating local innovation and the whole IVD industry.